Evidence map›Paper›PMID 37308598›Full record

ArticleEuropean journal of human genetics : EJHG2023

Defining critical educational components of informed consent for genetic testing: views of US-based genetic counselors and medical geneticists.

Miranda L G Hallquist, Maia J Borensztein, Curtis R Coughlin, Adam H Buchanan, W Andrew Faucett, Holly L Peay, Maureen E Smith, Eric P Tricou, Wendy R Uhlmann, Karen E Wain and 1 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Expanding what we know about rare genetic diseases.European journal of human genetics : EJHG · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Miranda L G HallquistGeisinger, Danville, PA, USA. mhallquist@geisinger.edu.ORCID 0000-0001-8554-2447
Maia J BorenszteinDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Curtis R CoughlinDepartment of Pediatrics and Center for Bioethics and Humanities, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Adam H BuchananGeisinger, Danville, PA, USA.ORCID 0000-0002-6518-2453
W Andrew FaucettGeisinger, Danville, PA, USA.
Holly L PeayRTI International, Genomics, Bioinformatics, and Translational Research Center, Raleigh, NC, USA.ORCID 0000-0002-3053-7453
Maureen E SmithDepartment of Medicine, Feinberg School of Medicine, Northwestern University, Evanston, IL, USA.ORCID 0000-0001-9480-1092
Eric P TricouGeisinger, Danville, PA, USA.
Wendy R UhlmannDivision of Genetic Medicine, Department of Internal Medicine; Department of Human Genetics; Center for Bioethics & Social Sciences in Medicine, University of Michigan, Ann Arbor, MI, USA.
Karen E WainGeisinger, Danville, PA, USA.
Kelly E OrmondDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, USA.

Funding

The Future of PharmGKB Funding Under NHGRIU41HG009649 · NHGRI · STANFORD UNIVERSITY · PI BUSTAMANTE, CARLOS DANIEL · 2017 to 2020
$13.4M
The Clinical Genome Resource - Expert Curation and EHR IntegrationU41HG009650 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BERG, JONATHAN S, GODDARD, KATRINA A. · 2017 to 2020
$13.3M
NHGRI NIH HHS U41 HG009649NHGRI NIH HHS U41HG009649NHGRI NIH HHS U41 HG009650NHGRI NIH HHS U41HG009650
6 · The paper itself

Abstract

The Clinical Genome Resource (ClinGen) Consent and Disclosure Recommendation (CADRe) framework proposes that key components of informed consent for genetic testing can be covered with a targeted discussion for many conditions rather than a time-intensive traditional genetic counseling approach. We surveyed US genetics professionals (medical geneticists and genetic counselors) on their response to scenarios that proposed core informed consent concepts for clinical genetic testing developed in a prior expert consensus process. The anonymous online survey included responses to 3 (of 6 possible) different clinical scenarios that summarized the application of the core concepts. There was a binary (yes/no) question asking respondents whether they agreed the scenarios included the minimum necessary and critical educational concepts to allow an informed decision. Respondents then provided open-ended feedback on what concepts were missing or could be removed. At least one scenario was completed by 238 respondents. For all but one scenario, over 65% of respondents agreed that the identified concepts portrayed were sufficient for an informed decision; the exome scenario had the lowest agreement (58%). Qualitative analysis of the open-ended comments showed no consistently mentioned concepts to add or remove. The level of agreement with the example scenarios suggests that the minimum critical educational components for pre-test informed consent proposed in our prior work is a reasonable starting place for targeted pre-test discussions. This may be helpful in providing consistency to the clinical practice of both genetics and non-genetics providers, meeting patients' informational needs, tailoring consent for psychosocial support, and in future guideline development.

Indexed as

CounselorsDisclosureEducational StatusGenetic CounselingGenetic TestingHumansInformed Consent

Identifiers

PMID37308598
PMCPMC10545703

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.